课题基金 / 基金详情

项目摘要

项目成果

DOROTHEA PARKER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. II. Description The Biomedical Technology Service Laboratory (BTSL) at Morehouse School of Medicine has been in existence for eighteen years. During this time, the BTSL has enhanced and supported the biomedical research of the basic and clinical science faculty at the institution tremendously. This support extends to the personnel in their laboratories as well as graduate and undergraduate students from the medical school and neighboring AUC institutions. The BTSL is the largest core facility at the institution occupying eight laboratory locations on the main campus. It provides consistent support for all types of multi-use equipment, research necessities, techniques, protocol development and specialized services. The specialized services offered are the production of polyclonal and monoclonal antibodies and 1D and 2D gel electrophoresis. The polyclonal and monoclonal core makes antibodies against conjugated synthetic peptides, chemokines, cytokines, cellular antigens, protein bands excised from polyacrylamide gels plus a variety of other proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BTSL
  • 批准号:
    8357155
  • 项目类别:
  • 资助金额:
    $16.61万
  • 财政年份:
    2011
  • 负责人:
    DOROTHEA PARKER
  • 依托单位:
BTSL
  • 批准号:
    8166167
  • 项目类别:
  • 资助金额:
    $15.38万
  • 财政年份:
    2010
  • 负责人:
    DOROTHEA PARKER
  • 依托单位:
BTSL
  • 批准号:
    7959155
  • 项目类别:
  • 资助金额:
    $13.18万
  • 财政年份:
    2009
  • 负责人:
    DOROTHEA PARKER
  • 依托单位:
BTSL
  • 批准号:
    7715261
  • 项目类别:
  • 资助金额:
    $19.33万
  • 财政年份:
    2008
  • 负责人:
    DOROTHEA PARKER
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究